Trends in Pharmacological Treatments for Acute Coronary Syndrome

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (31 March 2021)

Special Issue Editor


E-Mail Website
Guest Editor
School fo Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy
Interests: acute coronary syndrome; acute myocardial infarction; gender difference in CVD; non-obstructuìive CAD

Special Issue Information

Dear Colleagues,

The rate of mortality associated with ischemic heart disease (IHD) has decreased in Europe over the last few decades; however, IHD remains the single most common cause of death worldwide. Indeed, the in-hospital mortality rates of unselected patients with STEMI vary between 4 and 12%.

Pharmaceuticals is launching a Special Issue on “Trends in Pharmacological Treatments for Acute Coronary Syndrome”, which will be dedicated to the following specific issues:

  • gender differences;
  • MINOCA;
  • quality indicators for reducing the gap between optimal guideline-based treatment and actual care;
  • non-invasive imaging for acute and long-term management; and
  • the special patients subset (patients taking an oral anticoagulant, patients with renal insufficiency, the elderly, etc.).

Dr. Olivia Manfrini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • acute coronary syndrome
  • acute myocardial infarction
  • ST-segment elevation myocardial infarction
  • non-ST-segment elevation myocardial infarction
  • MINOCA
  • gender differences
  • comorbidity
  • elderly

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop